Pharmacovigilance practices are shifting from traditional workflow automation toward AI-assisted decision intelligence systems, according to reporting from Drug Discovery Trends. This transition reflects the industry’s move to leverage advanced analytics for more sophisticated drug safety monitoring and decision-making capabilities.